Dragnev, K. H., Redman, M. W., Reckamp, K. L., Khalil, M., Henick, B. S., Moon, J., Ahmadzai, P., LeBlanc, M. L., Carrizosa, D. R., Hesketh, P. J., Sigal, E. V., Allen, J., Saltos, A. N., Faller, B. A., Herbst, R. S., Blanke, C. D., Gray, J. E. (2025). PRAGMATICA-LUNG (SWOG S2302): A prospective, randomized study of ramucirumab plus pembrolizumab versus standard of care for participants previously treated with immunotherapy for stage IV or recurrent non-small cell lung cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.17_suppl.lba8671